Yahoo Inc. (NASDAQ:YHOO) said Monday it would buy mobile analytics startup Flurry Inc. for a reported $300 million, with teams from Weil Gotshal & Manges LLP and Goodwin Proctor LLP advising on either side of the deal. Yahoo! Inc. (NASDAQ:YHOO) stock performance was 0.96% in last session and finished the day at $33.60. Traded volume was 18.16million shares in the last session and the average volume of the stock remained 19.72million shares. The beta of the stock remained 1.01. Yahoo! Inc. (NASDAQ:YHOO) insider ownership is 0.40%.

Reynolds American Inc. (NYSE:RAI) agreed this month to buy Lorillard Inc., the largest U.S. maker of menthol cigarettes, for $25 billion. If the deal is cleared by antitrust regulators, the transaction will leave the 400-year-old American tobacco industry with just Reynolds and Altria Group Inc. controlling 90 percent of the market. Reynolds American, Inc. (NYSE:RAI) rose 0.31 percent to $58.16 Tuesday on volume of 2.86million shares. The intra-day range of the stock was $58.05 to $58.96. Reynolds American, Inc. (NYSE:RAI) has a market capitalization of $31.18billion.

FBR Capital Markets reiterated their outperform rating on shares of CNO Financial Group (NYSE:CNO) in a research note released on Friday morning. They currently have a $21.00 target price on the stock, up from their previous target price of $20.00. CNO Financial Group Inc (NYSE:CNO)’s stock on July 22, 2014 reported a increase of 0.53% to the closing price of $17.15. Its fifty two weeks range is $13.57 -$19.34. The total market capitalization recorded $3.74billion. The overall volume in the last trading session was 1.01million shares. In its share capital, CNO has 217.85million outstanding shares.

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ:ENDP) (ENL.TO), and BioDelivery Sciences International, Inc. (BDSI) announced on July 7 positive top-line results from its pivotal Phase III efficacy study of BEMA buprenorphine in opioid-experienced patients. BEMA buprenorphine is being developed for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in both patients who are opioid naive and opioid experienced. On Tuesday, shares of Endo International PLC (NASDAQ:ENDP) advanced 1.35% to close the day at $69.57. Company return on investment (ROI) is -8.50% and its monthly performance is recorded as -0.09%. Endo International PLC (NASDAQ:ENDP) quarterly revenue growth is 13.07%.

Ennis Inc (NYSE:EBF) declared a quarterly dividend on Thursday, June 26th, American Banking News.com reports. Shareholders of record on Monday, July 14th will be given a dividend of 0.175 per share on Friday, August 1st. This represents a $0.70 dividend on an annualized basis and a yield of 4.57%. Ennis, Inc. (NYSE:EBF) stock performance was 0.82% in last session and finished the day at $14.80. Traded volume was 44,790.00million shares in the last session and the average volume of the stock remained 90.74K shares. The beta of the stock remained 1.54. Ennis, Inc. (NYSE:EBF) insider ownership is 3.20%.